Search

everythinglearnresearchcommunity

for

Search:↓

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

CS12192 effectively treats alopecia areata with better safety than current options.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Combining pulsed prednisone with tofacitinib can lead to lasting hair regrowth in severe alopecia areata patients.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Adalimumab may cause severe hair loss in some patients.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tofacitinib treatment is used for teenagers with alopecia areata.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.